Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice

Ding Zhong Yang, Jing He, Ji Cheng Zhang, Zhuo Ren Wang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aim: To observe the biologic behavior of pancreatic cancer cells in vitro and in vivo, and to explore the potential value of angiostatin gene therapy for pancreatic cancer. Methods: The recombinant vector pcDNA3.1(+)-angiostatin was transfected into human pancreatic cancer cells PC-3 with Lipofectamine 2000, and paralleled with the vector and mock control. Angiostatin transcription and protein expression were determined by immunofluorescence and Western blot. The stable cell line was selected by G418. The supernatant was collected to treat endothelial cells. Cell proliferation and growth in vitro were observed under microscope. Cell growth curves were plotted. The troms-fected or untroms-fected cells overexpressing angiostatin vector were implanted subcutaneously into nude mice. The size of tumors was measured, and microvessel density count (MVD) in tumor tissues was assessed by immunohistochemistry with primary anti-CD34 antibody. Results: After transfected into PC-3 with Lipofectamine 2000 and selected by G418, macroscopic resistant cell clones were formed in the experimental group transfected with pcDNA 3.1(+)-angiostatin and vector control. But untreated cells died in the mock control. Angiostatin protein expression was detected in the experimental group by immunofluorescence and Western-blot. Cell proliferation and growth in vitro in the three groups were observed respectively under microscope. After treatment with supernatant, significant differences were observed in endothelial cell (ECV-304) growth in vitro. The cell proliferation and growth were inhibited. In nude mice model, markedly inhibited tumorigenesis and slowed tumor expansion were observed in the experimental group as compared to controls, which was parallel to the decreased microvessel density in and around tumor tissue. Conclusion: Angiostatin does not directly inhibit human pancreatic cancer cell proliferation and growth in vitro, but it inhibits endothelial cell growth in vitro. It exerts the anti-tumor functions through antiangiogenesis in a paracrine way in vivo.

Original languageEnglish (US)
Pages (from-to)4992-4996
Number of pages5
JournalWorld Journal of Gastroenterology
Volume11
Issue number32
DOIs
StatePublished - Aug 28 2005

Fingerprint

Angiostatins
Pancreatic Neoplasms
Nude Mice
Cell Proliferation
Growth
Endothelial Cells
Neoplasms
Microvessels
Fluorescent Antibody Technique
Western Blotting
Genetic Therapy
In Vitro Techniques
Anti-Idiotypic Antibodies
Carcinogenesis
Proteins
Clone Cells
Immunohistochemistry
Cell Line

Keywords

  • Angiostatin
  • Endothelial cell
  • Nude mice
  • Pancreatic cancer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice. / Yang, Ding Zhong; He, Jing; Zhang, Ji Cheng; Wang, Zhuo Ren.

In: World Journal of Gastroenterology, Vol. 11, No. 32, 28.08.2005, p. 4992-4996.

Research output: Contribution to journalArticle

Yang, Ding Zhong ; He, Jing ; Zhang, Ji Cheng ; Wang, Zhuo Ren. / Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice. In: World Journal of Gastroenterology. 2005 ; Vol. 11, No. 32. pp. 4992-4996.
@article{fb91b0a29fe94cf684d33b9e659f87ff,
title = "Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice",
abstract = "Aim: To observe the biologic behavior of pancreatic cancer cells in vitro and in vivo, and to explore the potential value of angiostatin gene therapy for pancreatic cancer. Methods: The recombinant vector pcDNA3.1(+)-angiostatin was transfected into human pancreatic cancer cells PC-3 with Lipofectamine 2000, and paralleled with the vector and mock control. Angiostatin transcription and protein expression were determined by immunofluorescence and Western blot. The stable cell line was selected by G418. The supernatant was collected to treat endothelial cells. Cell proliferation and growth in vitro were observed under microscope. Cell growth curves were plotted. The troms-fected or untroms-fected cells overexpressing angiostatin vector were implanted subcutaneously into nude mice. The size of tumors was measured, and microvessel density count (MVD) in tumor tissues was assessed by immunohistochemistry with primary anti-CD34 antibody. Results: After transfected into PC-3 with Lipofectamine 2000 and selected by G418, macroscopic resistant cell clones were formed in the experimental group transfected with pcDNA 3.1(+)-angiostatin and vector control. But untreated cells died in the mock control. Angiostatin protein expression was detected in the experimental group by immunofluorescence and Western-blot. Cell proliferation and growth in vitro in the three groups were observed respectively under microscope. After treatment with supernatant, significant differences were observed in endothelial cell (ECV-304) growth in vitro. The cell proliferation and growth were inhibited. In nude mice model, markedly inhibited tumorigenesis and slowed tumor expansion were observed in the experimental group as compared to controls, which was parallel to the decreased microvessel density in and around tumor tissue. Conclusion: Angiostatin does not directly inhibit human pancreatic cancer cell proliferation and growth in vitro, but it inhibits endothelial cell growth in vitro. It exerts the anti-tumor functions through antiangiogenesis in a paracrine way in vivo.",
keywords = "Angiostatin, Endothelial cell, Nude mice, Pancreatic cancer",
author = "Yang, {Ding Zhong} and Jing He and Zhang, {Ji Cheng} and Wang, {Zhuo Ren}",
year = "2005",
month = "8",
day = "28",
doi = "10.3748/wjg.v11.i32.4992",
language = "English (US)",
volume = "11",
pages = "4992--4996",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "32",

}

TY - JOUR

T1 - Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice

AU - Yang, Ding Zhong

AU - He, Jing

AU - Zhang, Ji Cheng

AU - Wang, Zhuo Ren

PY - 2005/8/28

Y1 - 2005/8/28

N2 - Aim: To observe the biologic behavior of pancreatic cancer cells in vitro and in vivo, and to explore the potential value of angiostatin gene therapy for pancreatic cancer. Methods: The recombinant vector pcDNA3.1(+)-angiostatin was transfected into human pancreatic cancer cells PC-3 with Lipofectamine 2000, and paralleled with the vector and mock control. Angiostatin transcription and protein expression were determined by immunofluorescence and Western blot. The stable cell line was selected by G418. The supernatant was collected to treat endothelial cells. Cell proliferation and growth in vitro were observed under microscope. Cell growth curves were plotted. The troms-fected or untroms-fected cells overexpressing angiostatin vector were implanted subcutaneously into nude mice. The size of tumors was measured, and microvessel density count (MVD) in tumor tissues was assessed by immunohistochemistry with primary anti-CD34 antibody. Results: After transfected into PC-3 with Lipofectamine 2000 and selected by G418, macroscopic resistant cell clones were formed in the experimental group transfected with pcDNA 3.1(+)-angiostatin and vector control. But untreated cells died in the mock control. Angiostatin protein expression was detected in the experimental group by immunofluorescence and Western-blot. Cell proliferation and growth in vitro in the three groups were observed respectively under microscope. After treatment with supernatant, significant differences were observed in endothelial cell (ECV-304) growth in vitro. The cell proliferation and growth were inhibited. In nude mice model, markedly inhibited tumorigenesis and slowed tumor expansion were observed in the experimental group as compared to controls, which was parallel to the decreased microvessel density in and around tumor tissue. Conclusion: Angiostatin does not directly inhibit human pancreatic cancer cell proliferation and growth in vitro, but it inhibits endothelial cell growth in vitro. It exerts the anti-tumor functions through antiangiogenesis in a paracrine way in vivo.

AB - Aim: To observe the biologic behavior of pancreatic cancer cells in vitro and in vivo, and to explore the potential value of angiostatin gene therapy for pancreatic cancer. Methods: The recombinant vector pcDNA3.1(+)-angiostatin was transfected into human pancreatic cancer cells PC-3 with Lipofectamine 2000, and paralleled with the vector and mock control. Angiostatin transcription and protein expression were determined by immunofluorescence and Western blot. The stable cell line was selected by G418. The supernatant was collected to treat endothelial cells. Cell proliferation and growth in vitro were observed under microscope. Cell growth curves were plotted. The troms-fected or untroms-fected cells overexpressing angiostatin vector were implanted subcutaneously into nude mice. The size of tumors was measured, and microvessel density count (MVD) in tumor tissues was assessed by immunohistochemistry with primary anti-CD34 antibody. Results: After transfected into PC-3 with Lipofectamine 2000 and selected by G418, macroscopic resistant cell clones were formed in the experimental group transfected with pcDNA 3.1(+)-angiostatin and vector control. But untreated cells died in the mock control. Angiostatin protein expression was detected in the experimental group by immunofluorescence and Western-blot. Cell proliferation and growth in vitro in the three groups were observed respectively under microscope. After treatment with supernatant, significant differences were observed in endothelial cell (ECV-304) growth in vitro. The cell proliferation and growth were inhibited. In nude mice model, markedly inhibited tumorigenesis and slowed tumor expansion were observed in the experimental group as compared to controls, which was parallel to the decreased microvessel density in and around tumor tissue. Conclusion: Angiostatin does not directly inhibit human pancreatic cancer cell proliferation and growth in vitro, but it inhibits endothelial cell growth in vitro. It exerts the anti-tumor functions through antiangiogenesis in a paracrine way in vivo.

KW - Angiostatin

KW - Endothelial cell

KW - Nude mice

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=24144462542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144462542&partnerID=8YFLogxK

U2 - 10.3748/wjg.v11.i32.4992

DO - 10.3748/wjg.v11.i32.4992

M3 - Article

VL - 11

SP - 4992

EP - 4996

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 32

ER -